PHAT   $9.33  -1.27% Market Closed After Close 9.34 0.11%

Phathom Pharmaceuticals Inc
Total Cash 276.24M
totalCashPerShare 4.635
EBITDA -252.07M
Total Debt 506.38M
quickRatio 6.108
currentRatio 6.484
Total Revenue 9.92M
debtToEquity
Revenue/Share 0.172
ROA -0.54069
ROE
grossProfits
freeCashflow -154.15M
operatingCashflow -215.45M
earningsGrowth
revenueGrowth
grossMargins 0.80147004
ebitdaMargins 0.0
operatingMargins -10.554339
profitMargins 0.0
enterpriseValue 1.32B
forwardPE -4.157044
floatShares 48.58M
sharesOutstanding 68.29M
sharesShort 17.56M
sharesShortPriorMonth 15.52M
dateShortInterest
sharesPercentSharesOut 0.26%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.94%
Short Ratio help_outline 15.67%
shortPercentOfFloat 0.36%
impliedSharesOutstanding
bookValue -3.99
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -297.11M
trailingEps -5.18%
forwardEps -4.33%
enterpriseToEbitda -5.26
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.49 3Q 2024
institutionsCount 178
lastUpdated Nov. 7, 2024, 3:04 a.m.